Skandinaviska Enskilda Banken AB (publ) - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 245 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$670,712
+104862.8%
23,2000.0%0.00%0.0%
Q3 2023$639
-23.9%
23,200
-16.8%
0.00%
-33.3%
Q2 2023$840
-99.4%
27,900
+298.6%
0.01%
+500.0%
Q3 2020$146,000
-91.8%
7,000
-90.7%
0.00%
-92.9%
Q4 2019$1,781,000
-8.6%
75,100
+5.9%
0.01%
-12.5%
Q3 2019$1,948,000
-17.1%
70,900
-0.1%
0.02%
-20.0%
Q2 2019$2,349,000
-16.9%
71,000
-12.0%
0.02%
-23.1%
Q1 2019$2,828,000
+13.3%
80,700
+7.5%
0.03%
+18.2%
Q4 2018$2,495,000
-35.9%
75,100
-2.8%
0.02%
-26.7%
Q3 2018$3,892,000
+27.3%
77,300
+51.3%
0.03%
+15.4%
Q2 2018$3,058,000
+3.5%
51,100
-20.8%
0.03%
-7.1%
Q1 2018$2,954,000
-6.3%
64,500
-18.5%
0.03%
+3.7%
Q4 2017$3,152,000
+32.5%
79,100
-17.8%
0.03%
+3.8%
Q3 2016$2,379,000
-51.1%
96,200
-59.7%
0.03%
-51.9%
Q2 2016$4,862,000
+4.8%
238,700
-21.5%
0.05%
+3.8%
Q1 2016$4,638,000
-15.6%
304,100
-25.6%
0.05%
-26.8%
Q4 2015$5,493,000408,7000.07%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders